Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study

Peer Review reports

Original Submission
11 Mar 2020	Submitted	Original manuscript
7 Apr 2020	Reviewed	Reviewer Report - JeanLuc Vachiery
14 Apr 2020	Reviewed	Reviewer Report - Elisabeth Domenica Hasler
26 May 2020	Author responded	Author comments - Evgeny Belyavskiy
Resubmission - Version 2
26 May 2020	Submitted	Manuscript version 2
15 Jun 2020	Reviewed	Reviewer Report - Elisabeth Domenica Hasler
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
16 Aug 2020	Editorially accepted
10 Sep 2020	Article published	10.1186/s12872-020-01671-2

Back to article page